Methods for Diagnosing and Treating Medical Conditions Associated With Oxidative Stress
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Aug 21, 2014
app pub date -
Aug 14, 2012
filing date -
Aug 18, 2011
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Non-mercaptalbumin-2 is used as a biomarker for diagnosing a medical condition associated with oxidative stress. A method for diagnosing a condition associated with oxidative stress includes determining the redox state of albumin at the cysteine residue at sequence position 34; quantifying the level of non-mercaptalbumin-2 present, non-mercaptalbumin-2 representing the albumin fraction irreversibly oxidized at cysteine 34; and comparing the result to a control level, wherein an elevated level of non-mercaptalbumin-2 as compared to the control level is indicative of the condition associated with oxidative stress. A method for the prevention and/or treatment of a medical condition associated with oxidative stress includes quantifying a level of non-mercaptalbumin-2 that is elevated as compared to a control, wherein such elevated level of non-mercaptalbumin-2 is indicative of the condition associated with oxidative stress; and restoring a control level of albumin by removing excess nonmercaptalbumin-2 and/or exogenously adding albumin.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully